Global Metabolomics Market – Industry Perspective, Comprehensive Analysis, Size, Share, Trends and Forecast, 2015 – 2021

Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global Metabolomics Market: Study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million)


The report covers forecast and analysis for the metabolomics market on a global and regional level. According to the report, the global demand for metabolomics was valued at over USD 675.0 million in 2015 and it is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% between 2016 and 2021.The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.

In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

Metabolites are substances or compounds found in the cell, they are intermediate products catalyzed by enzymes in the metabolism process. Signaling molecules, hormones, metabolic intermediates and secondary metabolites are some of the types of metabolites. Metabolism is the process to maintain living state of cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which certain compounds are synthesized that is required for cells to process, while breakdown of molecules for releasing energy is the catabolism. Metabolome is total set of metabolites present in a single organism. Metabolomics is study of chemical reactions related to metabolites and a field of analytical biochemistry. Metabolomics is used to compute and recognize the metabolites present in the cell via analytical technologies together with multi variant and statistical method for data interpretation.

Increasing scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for research is expected to drive the demand for the metabolomics market. Lack of adoption of metabolomics technology and complexity of the process can hamper the metabolomics market. Increasing research and development expenditure and existing demand from emerging economies and is likely to open new market avenues in the near future.

The metabolomics market is segmented on the basis of technology, indication, application and region. Mass spectrometry, capillary electrophoresis, high performance liquid chromatography, gas chromatography and nuclear magnetic resonance spectroscopy are some of the major segments based on technology. High performance liquid chromatography was largest technology segment for metabolomics market. Drug discovery, biomarker and nutrigenomics are some of the key application markets for metabolomics. Drug discovery emerged as dominating segment due to its significant role in optimization, prioritization and drug target validation and identification for research. Cardiology and oncology are the indication for metabolomics.

The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.

This report segments for metabolomics market as follows:

Metabolomics Market: Technology Segment Analysis

  • High performance liquid chromatography
  • Mass spectrometry
  • Capillary electrophoresis
  • Gas chromatography
  • Nuclear magnetic resonance spectroscopy

Metabolomics Market: Indication Segment Analysis

  • Cardiology
  • Oncology

Metabolomics Market: Application Segment Analysis

  • Drug discovery
  • Biomarker
  • Nutrigenomics

Metabolomics Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2015 – 2021(USD Million)
    • 2.2. Global metabolomics market: Snapshot
  • Chapter 3. Metabolomics Market – Global and Industry Analysis
    • 3.1. Metabolomics : Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global metabolomics market: Impact analysis
      • 3.2.2. Development of metabolomics data analysis software
      • 3.2.3. Scope of toxicological studies and clinical trials
    • 3.3. Market restraints
      • 3.3.1. Restraints of global metabolomics market: Impact analysis
      • 3.3.2. Validation of the process
      • 3.3.3. Lack of adoption of metabolomics technology
    • 3.4. Opportunities
      • 3.4.1. Untapped demand from emerging economies
      • 3.4.2. Surging research and development expenditure
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by technology segment
      • 3.6.2. Market attractiveness analysis by indication segment
      • 3.6.3. Market attractiveness analysis by application segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Metabolomics Market – Competitive Landscape
    • 4.1. Company market share, 2015
    • 4.2. Price trend analysis
  • Chapter 5. Global Metabolomics Market – Technology Segment Analysis
    • 5.1. Global metabolomics market: technology overview
      • 5.1.1. Global metabolomics market revenue share, by technology, 2015 – 2021
    • 5.2. High performance liquid chromatography
      • 5.2.1. Global high performance liquid chromatography market, by technology, 2015 – 2021 (USD Million)
    • 5.3. Mass spectrometry
      • 5.3.1. Global mass spectrometry market, by technology, 2015 – 2021 (USD Million)
    • 5.4. Capillary electrophoresis
      • 5.4.1. Global capillary electrophoresis market, by technology, 2015 – 2021 (USD Million)
    • 5.5. Gas chromatography
      • 5.5.1. Global gas chromatography market, by technology, 2015 – 2021 (USD Million)
    • 5.6. Nuclear magnetic resonance spectroscopy
      • 5.6.1. Global nuclear magnetic resonance spectroscopy market, by technology, 2015 – 2021 (USD Million)
  • Chapter 6. Global Metabolomics Market – Indication Segment Analysis
    • 6.1. Global metabolomics market: indication overview
      • 6.1.1. Global metabolomics market revenue share, by indication, 2015 – 2021
    • 6.2. Cardiology
      • 6.2.1. Global cardiology market, by indication, 2015 – 2021 (USD Million)
    • 6.3. Oncology
      • 6.3.1. Global oncology market, by indication, 2015 – 2021 (USD Million)
  • Chapter 7. Global Metabolomics Market – Applications Segment Analysis
    • 7.1. Global metabolomics market: indication overview
      • 7.1.1. Global metabolomics market revenue share, by indication, 2015 – 2021
    • 7.2. Drug discovery
      • 7.2.1. Global drug discovery market, by indication, 2015 – 2021 (USD Million)
    • 7.3. Biomarker
      • 7.3.1. Global biomarker market, by indication, 2015 – 2021 (USD Million)
    • 7.4. Nutrigenomics
      • 7.4.1. Global nutrigenomics market, by indication, 2015 – 2021 (USD Million)
  • Chapter 8. Global Metabolomics market – Regional Segment Analysis
    • 8.1. Global metabolomics market: Regional overview
      • 8.1.1. Global metabolomics market revenue share by region, 2015 – 2021
    • 8.2. North America
      • 8.2.1. North America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.2.2. North America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.2.3. North America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.2.3.1. U.S.
          • 8.2.3.1.1. U.S. metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.2.3.1.2. U.S. metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.2.3.1.3. U.S. metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe metabolomics market revenue, by a technology, 2015 – 2021 (USD Million)
      • 8.3.2. Europe metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.3.3. Europe metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.1. Germany
          • 8.3.3.1.1. Germany metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.1.2. Germany metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.1.3. Germany metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.2. France
          • 8.3.3.2.1. France metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.2.2. France metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.2.3. France metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.3. UK
          • 8.3.3.3.1. UK metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.3.2. UK metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.3.3. UK metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.4.2. Asia Pacific metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.4.3. Asia Pacific metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.1. China
          • 8.4.3.1.1. China metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.1.2. China metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.1.3. China metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.2. Japan
          • 8.4.3.2.1. Japan metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.2.2. Japan metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.2.3. Japan metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.3. India
          • 8.4.3.3.1. India metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.3.2. India metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.3.3. India metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.5.2. Latin America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.5.3. Latin America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.5.3.1. Brazil
          • 8.5.3.1.1. Brazil metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.5.3.1.2. Brazil metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.5.3.1.3. Brazil metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.6.2. Middle East and Africa metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.6.3. Middle East and Africa metabolomics market revenue, by application, 2015 – 2021 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Danaher Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Bruker Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Waters Corporation
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Metabolon, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Agilent Technologies
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Thermo Fisher Scientific
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Shimadzu Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Others
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments

List of Tables

1. Global metabolomics market estimates and forecast, 2015 – 2021(USD Million)
2. Global metabolomics market, by region, 2015 – 2021(USD Million)
3. Global metabolomics market, by technology, 2015 – 2021(USD Million)
4. Global metabolomics market, by indication, 2015 – 2021(USD Million)
5. Global metabolomics market, by applications, 2015 – 2021(USD Million)
6. Metabolomics– Key market driver analysis
7. Metabolomics– Key market restraint analysis
8. North America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
9. North America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
10. North America metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
11. U.S. metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
12. U.S. metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
13. U.S. metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
14. Europe metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
15. Europe metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
16. Europe metabolomics market revenue, byapplications, 2015 – 2021 (USD Million)
17. Germany metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
18. Germany metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
19. Germany metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
20. France metabolomicsmarket revenue, by technology, 2015 – 2021 (USD Million)
21. France metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
22. France metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
23. UK metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
24. UK metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
25. UK metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
26. Asia Pacific metabolomicsmarket revenue, by technology, 2015 – 2021 (USD Million)
27. Asia Pacific metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
28. Asia Pacific metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
29. China metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
30. China metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
31. China metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
32. Japan metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
33. Japan metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
34. Japan metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
35. India metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
36. India metabolomicsmarket revenue, by indication, 2015 – 2021 (USD Million)
37. India metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
38. Latin America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
39. Latin America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
40. Latin America metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
41. Brazil metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
42. Brazil metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
43. Brazil metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
44. Middle East and Africa metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
45. Middle East and Africa metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
46. Middle East and Africa metabolomics market revenue, by applications, 2015 – 2021 (USD Million)


List of Figures

1. Metabolomics market segmentation
2. Global metabolomics market revenue, 2015 – 2021(USD Million)
3. Metabolomics: Market attractiveness analysis, by technology segment
4. Metabolomics: Market attractiveness analysis, by indication segment
5. Metabolomics: Market attractiveness analysis, by applications segment
6. Metabolomics: Market attractiveness analysis, by regional segment
7. Global metabolomics marketer venue share by technology, 2015–2021
8. Global high performance liquid chromatography market, 2015 – 2021
9. Global mass spectrometry market, 2015–2021
10. Global capillary electrophoresis market, 2015–2021
11. Global gas chromatography market, 2015 – 2021
12. Global nuclear magnetic resonance spectroscopy market, 2015 – 2021
13. Global metabolomics market revenue share by indication, 2015 – 2021
14. Global cardiology market, 2015 – 2021
15. Global oncology market, 2015 – 2021
16. Global metabolomics market revenue share by applications, 2015–2021
17. Global drug discovery market, 2015 – 2021
18. Global biomarker market, 2015 – 2021
19. Global nutrigenomics market, 2015 – 2021
20. Global metabolomics market revenue share by region, 2015 – 2021


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?

Prove You are Human (required)

captcha
Enter Capcha Image Properly